United States  

Moderna Coronavirus Vaccine Trial Shows Promising Early Results

Seattle Times Tuesday, 19 May 2020
The first coronavirus vaccine to be tested in people appears to be safe and able to stimulate an immune response against the infection, the manufacturer, Moderna, announced Monday, offering a glint of hope to a world desperate for ways to stop the pandemic. The preliminary findings, in the first eight people who each received two […]
0
shares
ShareTweetSavePostSend
 
Video Credit: Reuters Studio - Published
News video: Moderna's COVID-19 vaccine shows early promise

Moderna's COVID-19 vaccine shows early promise 02:04

Early data from Moderna''s COVID-19 vaccine showed that it produced protective antibodies in a small group of healthy volunteers. This report produced by Zachary Goelman.

You Might Like


Related videos from verified sources

WBZ News Update For May 30 [Video]

WBZ News Update For May 30

Massachusetts coronavirus cases; Moderna enters second stage of coronavirus vaccine trial; Cool Sunday.

Credit: WBZ CBS Boston     Duration: 02:55Published
Cambridge Biotech Company Moderna Begins Second Stage Of Coronavirus Vaccine Study [Video]

Cambridge Biotech Company Moderna Begins Second Stage Of Coronavirus Vaccine Study

WBZ-TV's Ken MacLeod reports.

Credit: WBZ CBS Boston     Duration: 00:24Published
Pitt Researches Says Coronavirus Vaccine Likely Won't Be Available Until Early 2021 [Video]

Pitt Researches Says Coronavirus Vaccine Likely Won't Be Available Until Early 2021

Dr. William Klimstra told Pennsylvania Auditor General Eugene DePasquale that he doesn't believe a coronavirus vaccine will be available until early next year.

Credit: KDKA CBS 2 Pittsburgh     Duration: 00:52Published

Related news from verified sources

Moderna’s COVID-19 vaccine trial shows promising early results, it says

The first coronavirus vaccine to be tested in people appears to be safe and able to stimulate an immune response against the virus, its manufacturer, Moderna,...
ChicagoTribune

Coronavirus Vaccine Trial by Moderna Shows Promising Early Results

The company said its preliminary test in 8 healthy volunteers was safe. It is on an accelerated timetable to begin a larger human trial soon.
NYTimes.com

Moderna skyrockets 29% after its early trial for a coronavirus vaccine produced antibodies in all 45 patients (MRNA)

Moderna skyrockets 29% after its early trial for a coronavirus vaccine produced antibodies in all 45 patients (MRNA)
** · *Moderna announced on Monday that its early trial for its coronavirus vaccine produced antibodies in all patients. * · *Shares of the company surged...
Business Insider


Tweets about this